Figure S1. D. seriata mycelial growth inhibition assays for: (a) chitosan oligomers; (b) ε-polylysine; (c) S. rochei secondary metabolites; (d) S. lavendofoliae secondary metabolites; (e) ε-polylysine:chitosan (1:1 w/w) conjugates; (f) S. rochei secondary metabolites + chitosan oligomers (1:1 w/w); (g) S. lavendofoliae secondary metabolites + chitosan oligomers (1:1 w/w). The concentration of the treatments decreases from top to bottom (doses for each treatment are indicated in Error! Reference source not found.). The Petri dish in the bottom right corner shows the PDA control. Only one replicate per treatment and dose is shown.
. B. dothidea mycelial growth inhibition assays for: (a) chitosan oligomers; (b) ε-polylysine; (c) S. rochei secondary metabolites; (d) S. lavendofoliae secondary metabolites; (e) ε-polylysine:chitosan (1:1 w/w) conjugates; (f) S. rochei secondary metabolites + chitosan oligomers (1:1 w/w); (g) S. lavendofoliae secondary metabolites + chitosan oligomers (1:1 w/w). The concentration of the treatments decreases from top to bottom (doses for each treatment are indicated in Error! Reference source not found.). The Petri dish in the bottom right corner shows the PDA control. Only one replicates per treatment and dose is shown. Table S1 . Radial growth of mycelium (RG) and percentage of inhibition of radial growth (PIRG) of the different treatments against N. parvum 2, 4 and 5 days after inoculation. Means followed by the same letter are not significantly different according to Tukey's HSD test (p < 0.05). 0.00 ± 0.00 a 100.0 0.00 ± 0.00 a 100.0 0.00 ± 0.00 a 100.0 COS, EPL, MR and ML stand for chitosan oligomers, ε-polylysine, S. rochei secondary metabolites and S. lavendofoliae secondary metabolites, respectively. 
